A comparative evaluation of marketed analgesic drugs.
D000082:Acetaminophen / Q000008:administration & dosage / Q000627:therapeutic use; D000284:Administration, Oral; D000700:Analgesics / Q000627:therapeutic use*; D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use; D001381:Azepines / Q000008:administration & dosage / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003061:Codeine / Q000008:administration & dosage / Q000627:therapeutic use; D011431:Dextropropoxyphene / Q000008:administration & dosage / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D006801:Humans; D008528:Mefenamic Acid / Q000008:administration & dosage / Q000627:therapeutic use; D010166:Palliative Care; D010423:Pentazocine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D010615:Phenacetin / Q000008:administration & dosage / Q000627:therapeutic use; D010919:Placebos; D011395:Promazine / Q000008:administration & dosage / Q000627:therapeutic use
D000700:Analgesics; D001381:Azepines; D010919:Placebos; D000082:Acetaminophen; D008528:Mefenamic Acid; D010615:Phenacetin; D011395:Promazine; D001241:Aspirin; D010423:Pentazocine; D011431:Dextropropoxyphene; D003061:Codeine